🔎 Trials Near Me

Pradžia › Krūties ligos › Kalifornija

Krūties ligos klinikiniai tyrimai Kalifornija

6 tyrimai dėl Krūties ligos ieško dalyvių vietose Kalifornija.

Miestai Kalifornija

Oficialus tyrimo tekstas (anglų kalba)

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

  • UC Davis, Sacramento
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 94 · Moterims · Atnaujinta 2026-09-17 · NCT07505797

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

  • University of California, Los Angeles (Specimen Analysis only), Los Angeles
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT06780176

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • Providence Medical Foundation, Fullerton
  • California Research Institute, Los Angeles
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT05386108

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

  • Research Site, Duarte
  • Research Site, Palo Alto
Renkami dalyviai3 fazė
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07647328

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Ellison Clinic at Saint John's, Los Angeles
  • UCSF Medical Center at Mission Bay, San Francisco
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-07 · NCT05768139

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-23 · NCT06993844

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.